Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TIPARP | Q7Z3E1 | 20/20 | 0.70 |
| ▸ | CBLB | Q13191 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25321665 | 1.00 | TIPARP (0.70) | TIPARPCBLB | |
| SCHEMBL25321669 | 1.00 | TIPARP (0.70) | TIPARPCBLB | |
| SCHEMBL25320096 | 0.92 | TIPARP (0.69) | TIPARP | |
| SCHEMBL30550835 | 0.92 | TIPARP (0.69) | TIPARP | |
| SCHEMBL25320101 | 0.92 | TIPARP (0.69) | TIPARP | |
| SCHEMBL30550885 | 0.92 | TIPARP (0.72) | TIPARPCBLB | |
| SCHEMBL25320748 | 0.92 | TIPARP (0.72) | TIPARPCBLB | |
| SCHEMBL25320752 | 0.92 | TIPARP (0.72) | TIPARPCBLB | |
| SCHEMBL30550855 | 0.92 | TIPARP (0.67) | TIPARPCBLB | |
| SCHEMBL25322727 | 0.91 | TIPARP (0.69) | TIPARPCBLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024663-A1 | PARP7 INHIBITORS | GILEAD SCIENCES, INC. (US) | 2025-01-30 | — | — | WO | claimed |
| WO-2025024663-A1 | PARP7 INHIBITORS | GILEAD SCIENCES, INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| EP-4469448-A1 | PARP7 INHIBITORS | GILEAD SCIENCES, INC. (US) | 2024-12-04 | — | — | EP | disclosed |
| CN-118591537-A | PARP7 inhibitors | 吉利德科学公司 | 2024-09-03 | — | — | CN | disclosed |
| WO-2023147418-A1 | PARP7 INHIBITORS | GILEAD SCIENCES, INC. (US) | 2023-08-03 | — | — | WO | disclosed |